Skip to main content
Top
Published in: Orphanet Journal of Rare Diseases 1/2022

Open Access 01-12-2022 | Research

Incidence of Leber hereditary optic neuropathy in 2019 in Japan: a second nationwide questionnaire survey

Authors: Fumio Takano, Kaori Ueda, Daniel A. Godefrooij, Akiko Yamagami, Hiroto Ishikawa, Hideki Chuman, Hitoshi Ishikawa, Yasuhiro Ikeda, Taiji Sakamoto, Makoto Nakamura

Published in: Orphanet Journal of Rare Diseases | Issue 1/2022

Login to get access

Abstract

Background

Leber hereditary optic neuropathy (LHON) is an acute or subacute optic neuropathy that mainly affects young males. The first nationwide epidemiological survey of LHON was conducted in 2014 in Japan, and LHON was officially designated as a rare intractable disease by the Japanese government in 2015. We conducted a second survey of the annual incidence of LHON in 2019, and estimated the total number of patients with LHON in Japan.

Results

A questionnaire was sent to 997 facilities accredited by the Japanese Ophthalmological Society and/or affiliated with the councilors of the Japanese Neuro-Ophthalmology Society. Responses were received from 791 facilities, with a response rate of 79%. Fifty-five newly diagnosed cases (49 males and 6 females) of LHON were reported from 35 institutions in 2019, with a median age of 28.5 for males and 49.5 years for females. The total number of newly diagnosed cases was calculated as 69 (62 were males and 7 were females, 95% confidence interval 55–83), and the total number of patients was estimated to be 2491 (95% confidence interval: 1996–2986), suggesting a prevalence of LHON in Japan of 1:50,000.

Conclusion

The incidence of LHON in 2019 was lower than the estimate in 2014, whereas its prevalence may be similar to that reported in other countries. The accurate estimation of the incidence and prevalence of patients with LHON requires prospective registration.
Literature
1.
go back to reference Meyerson C, Van Stavern G, McClelland C. Leber hereditary optic neuropathy: current perspectives. Clin Ophthalmol (Auckland, NZ). 2015;9:1165–76. Meyerson C, Van Stavern G, McClelland C. Leber hereditary optic neuropathy: current perspectives. Clin Ophthalmol (Auckland, NZ). 2015;9:1165–76.
2.
go back to reference Kirkman MA, Yu-Wai-Man P, Korsten A, Leonhardt M, Dimitriadis K, De Coo IF, et al. Gene-environment interactions in Leber hereditary optic neuropathy. Brain. 2009;132:2317–26.CrossRef Kirkman MA, Yu-Wai-Man P, Korsten A, Leonhardt M, Dimitriadis K, De Coo IF, et al. Gene-environment interactions in Leber hereditary optic neuropathy. Brain. 2009;132:2317–26.CrossRef
3.
go back to reference Nakamura M, Mimura O, Wakakura M, Inatani M, Nakazawa T, Shiraga F. Designation criteria for Leber’s hereditary optic neuropathy. Nippon Ganka Gakkai Zasshi. 2015;119:339–46.PubMed Nakamura M, Mimura O, Wakakura M, Inatani M, Nakazawa T, Shiraga F. Designation criteria for Leber’s hereditary optic neuropathy. Nippon Ganka Gakkai Zasshi. 2015;119:339–46.PubMed
4.
go back to reference Jancic J, Dejanovic I, Samardzic J, Radovanovic S, Pepic A, Kosanovic-Jakovic N, et al. Leber hereditary optic neuropathy in the population of Serbia. Eur J Paediatr Neurol. 2014;18:354–9.CrossRef Jancic J, Dejanovic I, Samardzic J, Radovanovic S, Pepic A, Kosanovic-Jakovic N, et al. Leber hereditary optic neuropathy in the population of Serbia. Eur J Paediatr Neurol. 2014;18:354–9.CrossRef
5.
go back to reference Ueda K, Morizane Y, Shiraga F, Shikishima K, Ishikawa H, Wakakura M, et al. Nationwide epidemiological survey of Leber hereditary optic neuropathy in Japan. J Epidemiol. 2017;27:447–50.CrossRef Ueda K, Morizane Y, Shiraga F, Shikishima K, Ishikawa H, Wakakura M, et al. Nationwide epidemiological survey of Leber hereditary optic neuropathy in Japan. J Epidemiol. 2017;27:447–50.CrossRef
6.
go back to reference Imachi J. Leber’s disease: its genetics, clinical pictures, therapy and histo-pathology (author’s transl). Nippon Ganka Gakkai Zasshi. 1973;77:1658–735.PubMed Imachi J. Leber’s disease: its genetics, clinical pictures, therapy and histo-pathology (author’s transl). Nippon Ganka Gakkai Zasshi. 1973;77:1658–735.PubMed
7.
go back to reference Hotta Y, Fujiki K, Hayakawa M, Nakajima A, Kanai A, Mashima Y, et al. Clinical features of Japanese Leber’s hereditary optic neuropathy with 11778 mutation of mitochondrial DNA. Jpn J Ophthalmol. 1995;39:96–108.PubMed Hotta Y, Fujiki K, Hayakawa M, Nakajima A, Kanai A, Mashima Y, et al. Clinical features of Japanese Leber’s hereditary optic neuropathy with 11778 mutation of mitochondrial DNA. Jpn J Ophthalmol. 1995;39:96–108.PubMed
8.
go back to reference Sadun AA, Carelli V, Salomao SR, Berezovsky A, Quiros P, Sadun F, et al. A very large Brazilian pedigree with 11778 Leber’s hereditary optic neuropathy. Trans Am Ophthalmol Soc. 2002;100:169–78 (discussion 78-9).PubMedPubMedCentral Sadun AA, Carelli V, Salomao SR, Berezovsky A, Quiros P, Sadun F, et al. A very large Brazilian pedigree with 11778 Leber’s hereditary optic neuropathy. Trans Am Ophthalmol Soc. 2002;100:169–78 (discussion 78-9).PubMedPubMedCentral
9.
go back to reference De Vries DD, Went LN, Bruyn GW, Scholte HR, Hofstra RM, Bolhuis PA, et al. Genetic and biochemical impairment of mitochondrial complex I activity in a family with Leber hereditary optic neuropathy and hereditary spastic dystonia. Am J Hum Genet. 1996;58:703–11.PubMedPubMedCentral De Vries DD, Went LN, Bruyn GW, Scholte HR, Hofstra RM, Bolhuis PA, et al. Genetic and biochemical impairment of mitochondrial complex I activity in a family with Leber hereditary optic neuropathy and hereditary spastic dystonia. Am J Hum Genet. 1996;58:703–11.PubMedPubMedCentral
10.
go back to reference Dai Y, Wang C, Nie Z, Han J, Chen T, Zhao X, et al. Mutation analysis of Leber’s hereditary optic neuropathy using a multi-gene panel. Biomed Rep. 2018;8:51–8.PubMed Dai Y, Wang C, Nie Z, Han J, Chen T, Zhao X, et al. Mutation analysis of Leber’s hereditary optic neuropathy using a multi-gene panel. Biomed Rep. 2018;8:51–8.PubMed
11.
go back to reference Zhou HP, Ishikawa H, Yasumoto R, Sakurai K, Sawamura H. Leber hereditary optic neuropathy harboring a rare m.12811 T>C mitochondrial DNA mutation. Can J Ophthalmol. 2021;56:e82–4.CrossRef Zhou HP, Ishikawa H, Yasumoto R, Sakurai K, Sawamura H. Leber hereditary optic neuropathy harboring a rare m.12811 T>C mitochondrial DNA mutation. Can J Ophthalmol. 2021;56:e82–4.CrossRef
12.
go back to reference Hashimoto S, Fukutomi K, Nagai M, Nakamura Y, Yanagawa H, Sasaki R, et al. A method of interval estimation for the number of patients in the nationwide epidemiological survey on the intractable disease (in Japanese). Nihon Koshu Eisei Zasshi. 1991;38:880–3.PubMed Hashimoto S, Fukutomi K, Nagai M, Nakamura Y, Yanagawa H, Sasaki R, et al. A method of interval estimation for the number of patients in the nationwide epidemiological survey on the intractable disease (in Japanese). Nihon Koshu Eisei Zasshi. 1991;38:880–3.PubMed
13.
go back to reference Fukushima W, Fujioka M, Kubo T, Tamakoshi A, Nagai M, Hirota Y. Nationwide epidemiologic survey of idiopathic osteonecrosis of the femoral head. Clin Orthop Relat Res. 2010;468:2715–24.CrossRef Fukushima W, Fujioka M, Kubo T, Tamakoshi A, Nagai M, Hirota Y. Nationwide epidemiologic survey of idiopathic osteonecrosis of the femoral head. Clin Orthop Relat Res. 2010;468:2715–24.CrossRef
14.
go back to reference Nakamura Y, Matsumoto T, Tamakoshi A, Kawamura T, Seino Y, Kasuga M. Prevalence of idiopathic hypoparathyroidism and pseudohypoparathyroidism in Japan. J Epidemiol. 2000;10:29–33.CrossRef Nakamura Y, Matsumoto T, Tamakoshi A, Kawamura T, Seino Y, Kasuga M. Prevalence of idiopathic hypoparathyroidism and pseudohypoparathyroidism in Japan. J Epidemiol. 2000;10:29–33.CrossRef
16.
go back to reference Sharma LK, Tiwari M, Rai NK, Bai Y. Mitophagy activation repairs Leber’s hereditary optic neuropathy associated mitochondrial dysfunction and improves cell survival. Hum Mol Genet. 2018;28:422–33.CrossRef Sharma LK, Tiwari M, Rai NK, Bai Y. Mitophagy activation repairs Leber’s hereditary optic neuropathy associated mitochondrial dysfunction and improves cell survival. Hum Mol Genet. 2018;28:422–33.CrossRef
17.
go back to reference Giordano C, Montopoli M, Perli E, Orlandi M, Fantin M, Ross-Cisneros FN, et al. Oestrogens ameliorate mitochondrial dysfunction in Leber’s hereditary optic neuropathy. Brain. 2011;134:220–34.CrossRef Giordano C, Montopoli M, Perli E, Orlandi M, Fantin M, Ross-Cisneros FN, et al. Oestrogens ameliorate mitochondrial dysfunction in Leber’s hereditary optic neuropathy. Brain. 2011;134:220–34.CrossRef
18.
go back to reference Vestergaard N, Rosenberg T, Torp-Pedersen C, Vorum H, Andersen CU, Aasbjerg K. Increased mortality and comorbidity associated with Leber’s hereditary optic neuropathy: a nationwide cohort study. Invest Ophthalmol Vis Sci. 2017;58:4586–92.CrossRef Vestergaard N, Rosenberg T, Torp-Pedersen C, Vorum H, Andersen CU, Aasbjerg K. Increased mortality and comorbidity associated with Leber’s hereditary optic neuropathy: a nationwide cohort study. Invest Ophthalmol Vis Sci. 2017;58:4586–92.CrossRef
20.
go back to reference Godefrooij DA, de Wit GA, Uiterwaal CS, Imhof SM, Wisse RP. Age-specific incidence and prevalence of keratoconus: a nationwide registration study. Am J Ophthalmol. 2017;175:169–72.CrossRef Godefrooij DA, de Wit GA, Uiterwaal CS, Imhof SM, Wisse RP. Age-specific incidence and prevalence of keratoconus: a nationwide registration study. Am J Ophthalmol. 2017;175:169–72.CrossRef
Metadata
Title
Incidence of Leber hereditary optic neuropathy in 2019 in Japan: a second nationwide questionnaire survey
Authors
Fumio Takano
Kaori Ueda
Daniel A. Godefrooij
Akiko Yamagami
Hiroto Ishikawa
Hideki Chuman
Hitoshi Ishikawa
Yasuhiro Ikeda
Taiji Sakamoto
Makoto Nakamura
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2022
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/s13023-022-02478-4

Other articles of this Issue 1/2022

Orphanet Journal of Rare Diseases 1/2022 Go to the issue